Lupus-like syndrome associated with anti-tumour necrosis factorα therapy

被引：0
|
作者：
Sun, S [1 ]
Martin, L [1 ]
机构：
[1] Univ Calgary, Dept Internal Med, Calgary, AB, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2003年 / 30卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1884 / 1884
页数：1
相关论文
共 50 条
  • [21] Retention on anti-tumour necrosis factor therapy: the Waikato experience
    Ip, Ken
    Hartley, Lorraine
    Solanki, Kamal
    White, Douglas
    NEW ZEALAND MEDICAL JOURNAL, 2015, 128 (1415) : 34 - 40
  • [22] Anti-Tumour Necrosis Factor Therapy for Ulcerative ColitisEvidence to Date
    Chandrashekhar Thukral
    Adam Cheifetz
    Mark A. Peppercorn
    Drugs, 2006, 66 : 2059 - 2065
  • [23] Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey
    Michel De Bandt
    Jean Sibilia
    Xavier Le Loët
    Sebastian Prouzeau
    Bruno Fautrel
    Christian Marcelli
    Eric Boucquillard
    Jean Louis Siame
    Xavier Mariette
    Arthritis Research & Therapy, 7
  • [24] AUTOANTIBODIES AND SYSTEMIC LUPUS ERYTHEMATOSUS INDUCED BY ANTI-TUMOUR NECROSIS FACTOR ALPHA THERAPY IN RHEUMATOID ARTHRITIS
    Oliveira, D. Santos
    Martins, A.
    Martins, F. R.
    Pinheiro, F. Oliveira
    Rato, M.
    Fonseca, D.
    Fernandes, B. M.
    Garcia, S.
    Vaz, C.
    Bernardes, M.
    Costa, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 318 - 318
  • [25] Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy:: a French national survey
    De Bandt, M
    Sibilia, J
    Le Loët, X
    Prouzeau, S
    Fautrel, B
    Marcelli, C
    Boucquillard, E
    Siame, JL
    Mariette, X
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (03) : R545 - R551
  • [26] Immune profiling of lupus miliaris disseminatus faciei and successful management with anti-tumour necrosis factor therapy
    Alexanian, C.
    Liakos, W.
    Toussi, A.
    Kao, J.
    Cheng, M. Y.
    Wang, E. A.
    Nava, J.
    Tran, M.
    Marusina, A. I.
    Merleev, A. A.
    Leal, A. R.
    Fung, M. A.
    Le, S. T.
    Luxardi, G.
    Maverakis, E.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (05) : 910 - 914
  • [27] Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
    Konstantinos Papamichael
    Severine Vermeire
    World Journal of Gastroenterology, 2015, (16) : 4773 - 4778
  • [28] Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
    Leandro, Maria J.
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (05)
  • [29] Mycobacterium marinum infection complicated by anti-tumour necrosis factor therapy
    Ramos, Jose M.
    Garcia-Sepulcre, Mariana F.
    Rodriguez, Juan C.
    Padilla, Sergio
    Gutierrez, Felix
    JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 59 (05) : 617 - 621
  • [30] Anti-tumour necrosis factor a therapy in rheumatoid arthritis: an update on safety
    Hyrich, KL
    Silman, AJ
    Watson, KD
    Symmons, DPM
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (12) : 1538 - 1543
12345